Agoracom

Biotech is not the first place to find stocks with stable earnings growth and price performance.

Of 245 companies in the Medical-Biomed/Biotech industry group, only 20 have a long enough profit track record to even produce an EPS Stability Rating.

Scores of companies are development-stage enterprises, their activities confined mainly to the lab. Many haven't even generated any sales yet, but there is huge potiential and if you have ever wanted to make 10 or 20 times your investment this is the industry.